Clinical Trial

Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）

Study acronym: ENDEAVOR
Recruiting
View on ClinicalTrials.gov →
Summary
In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used multi-omics technology to understand the prognostic value of its biomarkers, and provided new ideas and evidence for the pathogenesis, clinical diagnosis and treatment of IE.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-07-20; most recent amendment 2024-07-10.
Status change: Not Yet Recruiting → Recruiting 2024-07-10
Trial Details
NCT Number NCT05965362
Lead Sponsor First Affiliated Hospital Xi'an Jiaotong University
Collaborators: 521 Hospital of NORINCO Group, Shaanxi Provincial People's Hospital, Xiangyang Central Hospital, Henan Provincial People's Hospital
Conditions Infective Endocarditis
Enrollment 2,000 participants
Start Date 2024-05-09
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-12